DUAL CHECKPOINT ABROGATION IS SYNERGISTIC IN KRAS-MUTANT CANCER

被引:0
|
作者
不详
机构
关键词
D O I
10.1158/2159-8290.CD-RW2015-133
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:903 / 903
页数:1
相关论文
共 50 条
  • [41] Suppression of KRas-mutant cancer through the combined inhibition of KRAS with PLK1 and ROCK
    Wang, Jieqiong
    Hu, Kewen
    Guo, Jiawei
    Cheng, Feixiong
    Lv, Jing
    Jiang, Wenhao
    Lu, Weiqiang
    Liu, Jinsong
    Pang, Xiufeng
    Liu, Mingyao
    NATURE COMMUNICATIONS, 2016, 7
  • [42] Dual inhibition of CDK4 and FYN leads to selective cell death in KRAS-mutant colorectal cancer
    Yan Wang
    Rongjie Lin
    Huan Ling
    Yuan Ke
    Yangyang Zeng
    Yudi Xiong
    Qian Zhou
    Fuxiang Zhou
    Yunfeng Zhou
    Signal Transduction and Targeted Therapy, 4
  • [43] Dual inhibition of CDK4 and FYN leads to selective cell death in KRAS-mutant colorectal cancer
    Wang, Yan
    Lin, Rongjie
    Ling, Huan
    Ke, Yuan
    Zeng, Yangyang
    Xiong, Yudi
    Zhou, Qian
    Zhou, Fuxiang
    Zhou, Yunfeng
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2019, 4 (1)
  • [44] Synthetic Lethal Vulnerabilities in KRAS-Mutant Cancers
    Aguirre, Andrew J.
    Hahn, William C.
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2018, 8 (08):
  • [45] Small molecular inhibitors for KRAS-mutant cancers
    Wu, Xuan
    Song, Wenping
    Cheng, Cheng
    Liu, Ziyang
    Li, Xiang
    Cui, Yu
    Gao, Yao
    Li, Ding
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [46] Role of silent mutations in KRAS-mutant tumors
    Lu Jun
    Zhou Chao
    Pan Feng
    Liu Hongyu
    Jiang Haohua
    Zhong Hua
    Han Baohui
    中华医学杂志英文版, 2025, 138 (03)
  • [47] Eliminating protective autophagy in KRAS-mutant cancers
    Seton-Rogers, Sarah
    NATURE REVIEWS CANCER, 2019, 19 (05) : 247 - 247
  • [48] Eliminating protective autophagy in KRAS-mutant cancers
    Sarah Seton-Rogers
    Nature Reviews Cancer, 2019, 19 : 247 - 247
  • [49] Osteopontin drives KRAS-mutant lung adenocarcinoma
    Giopanou, Ioanna
    Kanellakis, Nikolaos, I
    Giannou, Anastasios D.
    Lilis, Ioannis
    Marazioti, Antonia
    Spella, Magda
    Papaleonidopoulos, Vassilios
    Simoes, Davina C. M.
    Zazara, Dimitra E.
    Agalioti, Theodora
    Moschos, Charalampos
    Magkouta, Sophia
    Kalomenidis, Ioannis
    Panoutsakopoulou, Vily
    Lamort, Anne-Sophie
    Stathopoulos, Georgios T.
    Psallidas, Ioannis
    CARCINOGENESIS, 2020, 41 (08) : 1134 - 1144
  • [50] A step towards treating KRAS-mutant NSCLC
    Goldberg, Sarah B.
    Schlessinger, Joseph
    Boyer, Julie L.
    Herbst, Roy S.
    LANCET ONCOLOGY, 2013, 14 (01): : 3 - 5